Temozolomide in Treating Patients With Low-Grade Glioma

NCT00313729 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

CNS Tumor, Adult

Interventions

DRUG: temozolomide

Sponsor

University of California, San Francisco